Pathophysiology Dept., School of Medicine, National and Kapodistrian University of Athens, Greece & Academic Joint Rheumatology Program, School of Medicine, National and Kapodistrian University of Athens, Greece
Volume 27, Issue 2, June 2016
Sign in to download the Issue in PDF format.
1202588244
Mediterr J Rheumatol 2016;27(2):75-7
Article Links
Levels of miRNA miR200b-5p (miR200b*) in the minor salivary glands (MSG) of patients with Sjögren’s syndrome: Possible prognostic value for future lymphoma development?
References
- Tzioufas A G, Kapsogeorgou E K, Moutsopoulos H M. Pathogenesis of Sjögren’s syndrome: what we know and what we should learn. J Autoimmun 2012;39:4-8.
- Christodoulou M I, Kapsogeorgou E K, Moutsopoulos H M. Characteristics of the minor salivary gland infiltrates in Sjögren’s syndrome. J Autoimmun 2010;34:400-7.
- Manoussakis M N, Boiu S, Korkolopoulou P, Kapsogeorgou E K, Kavantzas N, Ziakas P, et al. Rates of infiltration by macrophages and dendritic cells and expression of interleukin-18 and interleukin-12 in the chronic inflammatory lesions of Sjögren’s syndrome: correlation with certain features of immune hyperactivity and factors associated with high risk of lymphoma development. Arthritis Rheum 2007;56:3977-88.
- Theander E, Vasaitis L, Baecklund E, Nordmark G, Warfvinge G, Liedholm R, et al. Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren’s syndrome. Ann Rheum Dis 2011;70:1363-8.
- Gerli R, Muscat C, Giansanti M, Danieli M G, Sciuto M, Gabrielli A, et al. Quantitative assessment of salivary gland inflammatory infiltration in primary Sjögren’s syndrome: its relationship to different demographic, clinical and serological features of the disorder. Br J Rheumatol 1997;36:969-75.
- Kapsogeorgou E K, Christodoulou MI, Panagiotakos D B, Paikos S, Tassidou A, Tzioufas A G, et al. Minor salivary gland inflammatory lesions in Sjögren’s syndrome: do they evolve? J Rheumatol 2013;40:1566-71.
- Winter J, Jung S, Keller S, Gregory R I, Diederichs S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 2009;11:228-34.
- Pauley K M, Cha S, Chan E K. MicroRNA in autoimmunity and autoimmune diseases. J Autoimmun 2009;32:189-94.
- Alevizos I, Alexander S, Turner R J, Illei G G. MicroRNA expression profiles as biomarkers of minor salivary gland inflammation and dysfunction in Sjögren’s syndrome. Arthritis Rheum 2011;63:535-44.
- Gourzi V C, Kapsogeorgou E K, Kyriakidis N C, Tzioufas A G. Study of microRNAs (miRNAs) that are predicted to target the autoantigens Ro/SSA and La/SSB in primary Sjögren’s Syndrome. Clin Exp Immunol 2015;182:14-22.
- Feng B, Wang R, Chen L B. Review of miR-200b and cancer chemosensitivity. Biomed Pharmacother 2012;66:397-402.
- Hummel R, Hussey D J, Haier J. MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types. Eur J Cancer 2010;46:298-311.
- Sun L, Yao Y, Liu B, Lin Z, Lin L, Yang M, et al. MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1. Oncogene 2012;31:432-45.